Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Warby Parker Inc. (WRBY) Stock Forecast & Price Prediction United States | NYSE | Healthcare | Medical Instruments & Supplies
$27.59
-0.32 (-1.15%)Did WRBY Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Warby Parker is one of their latest high-conviction picks.
Based on our analysis of 3 Wall Street analysts, WRBY has a bullish consensus with a median price target of $32.00 (ranging from $24.00 to $35.00). The overall analyst rating is Strong Buy (8.6/10). Currently trading at $27.59, the median forecast implies a 16.0% upside. This outlook is supported by 10 Buy, 4 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for WRBY.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 29, 2026 | B of A Securities | Robert Ohmes | Buy | Initiates | $33.00 |
| May 8, 2026 | UBS | Neutral | Maintains | $N/A | |
| May 7, 2026 | BTIG | Buy | Maintains | $N/A | |
| Mar 17, 2026 | Citigroup | Neutral | Maintains | $N/A | |
| Feb 20, 2026 | Telsey Advisory Group | Outperform | Maintains | $N/A | |
| Feb 10, 2026 | Telsey Advisory Group | Outperform | Maintains | $N/A | |
| Dec 16, 2025 | Piper Sandler | Overweight | Maintains | $N/A | |
| Dec 12, 2025 | Stifel | Hold | Maintains | $N/A | |
| Dec 11, 2025 | BTIG | Buy | Maintains | $N/A | |
| Nov 18, 2025 | Telsey Advisory Group | Outperform | Maintains | $N/A | |
| Nov 7, 2025 | UBS | Neutral | Maintains | $N/A | |
| Nov 7, 2025 | Telsey Advisory Group | Outperform | Maintains | $N/A | |
| Nov 6, 2025 | BTIG | Buy | Maintains | $N/A | |
| Oct 31, 2025 | Telsey Advisory Group | Outperform | Maintains | $N/A | |
| Oct 28, 2025 | BTIG | Buy | Reiterates | $N/A | |
| Oct 6, 2025 | Goldman Sachs | Buy | Maintains | $N/A | |
| Aug 8, 2025 | UBS | Neutral | Maintains | $N/A | |
| Aug 8, 2025 | Stifel | Hold | Maintains | $N/A | |
| Aug 8, 2025 | Telsey Advisory Group | Outperform | Maintains | $N/A | |
| Aug 7, 2025 | Telsey Advisory Group | Outperform | Maintains | $N/A |
The following stocks are similar to Warby Parker based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Warby Parker Inc. has a market capitalization of $3.39B with a P/E ratio of 2,761.0x. The company generates $890.57M in trailing twelve-month revenue with a 0.2% profit margin.
Revenue growth is +8.3% quarter-over-quarter, while maintaining an operating margin of +1.0% and return on equity of +0.4%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Sells stylish, affordable eyewear online and in-store.
Warby Parker operates on a direct-to-consumer model, eliminating middlemen to offer prescription glasses at lower prices. They generate revenue through the sale of eyewear products, including glasses, sunglasses, and contact lenses, while providing a unique home try-on service that enhances customer convenience.
Founded in 2010, the company has established a strong online presence complemented by physical stores. Warby Parker also engages in social initiatives, distributing eyewear to those in need, which bolsters its brand reputation and market presence.
Healthcare
Medical Instruments & Supplies
2,275
Mr. Neil Harris Blumenthal
United States
2021
Warby Parker Inc. (NYSE: WRBY) will release Q2 2026 financial results on August 6, 2026, before market open, followed by a conference call at 8:00 a.m. ET.
Warby Parker's upcoming financial results and outlook can impact stock performance, providing insights into growth, profitability, and market strategy, crucial for investor decisions.
Warby Parker Inc. (NYSE:WRBY) stock increased as investors shifted to growth stocks, with the Consumer Discretionary sector driving market gains; Nasdaq rose 1.34%, S&P 500 up 1.12%.
Warby Parker's stock rise signals increased investor interest in growth stocks, reflecting positive sentiment in the Consumer Discretionary sector, which can boost overall market momentum.
Neil Blumenthal sold 63,040 Class A shares for ~$1.89 million at ~$30.03 per share on May 19, 2026, reducing his holdings by 12.28%.
Neil Blumenthal's sale of 12.28% of his Class A shares may signal a lack of confidence or a need for liquidity, potentially impacting investor sentiment and stock performance.
Director Youngme Moon sold 10,000 shares at $26.53 each on June 12, 2026, totaling ~$265,000, decreasing her holdings by 27.73% from 36,061 to 26,061 shares.
Director Youngme Moon's sale of 27.73% of her shares may signal a lack of confidence in the company's future or personal liquidity needs, potentially affecting stock performance and investor sentiment.
Warby Parker Inc. (NYSE: WRBY) will present at the 2026 Baird Global Consumer, Technology & Services Conference on June 2, 2026, at 12:50 PM ET. The presentation will be webcast live.
Warby Parker's presentation at a major conference could signal growth potential and attract investor interest, impacting stock performance and market perception.
Warby Parker co-CEOs Neil Blumenthal and Dave Gilboa announced new 'intelligent eyewear' in collaboration with Google and Samsung, highlighting competition in the wearable tech market.
Warby Parker's partnership with Google and Samsung on 'intelligent eyewear' signals innovation, potential market expansion, and increased competition, which could impact stock performance and growth prospects.
Based on our analysis of 3 Wall Street analysts, Warby Parker Inc. (WRBY) has a median price target of $32.00. The highest price target is $35.00 and the lowest is $24.00.
According to current analyst ratings, WRBY has 10 Buy ratings, 4 Hold ratings, and 0 Sell ratings. The stock is currently trading at $27.59. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict WRBY stock could reach $32.00 in the next 12 months. This represents a 16.0% increase from the current price of $27.59. Please note that this is a projection by Wall Street analysts and not a guarantee.
Warby Parker operates on a direct-to-consumer model, eliminating middlemen to offer prescription glasses at lower prices. They generate revenue through the sale of eyewear products, including glasses, sunglasses, and contact lenses, while providing a unique home try-on service that enhances customer convenience.
The highest price target for WRBY is $35.00 from at , which represents a 26.9% increase from the current price of $27.59.
The lowest price target for WRBY is $24.00 from at , which represents a -13.0% decrease from the current price of $27.59.
The overall analyst consensus for WRBY is bullish. Out of 3 Wall Street analysts, 10 rate it as Buy, 4 as Hold, and 0 as Sell, with a median price target of $32.00.
Stock price projections, including those for Warby Parker Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.